Jay Garza
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Jay Garza has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Benjamin F. Chong
Department of Dermatology University of Texas Southwestern Medical Center Dallas Texas USA
2 shared publications - Abbas Rana
Division of Abdominal Transplantation, Michael E. DeBakey Department of Surgery Baylor College of Medicine Houston Texas USA
1 shared publication Alexis Shaffi
Department of Surgery, Baylor College of Medicine, Houston, Texas, USA
1 shared publicationAndrew Civitello
Department of Medicine, Baylor College of Medicine, Houston, Texas, USA
1 shared publicationBhamidipati Murthy
Department of Medicine, Baylor College of Medicine, Houston, Texas, USA
1 shared publicationChristine A. O’mAhony
Department of Surgery, Baylor College of Medicine, Houston, Texas, USA
1 shared publication
Latest Publications
- 19 February 2026
- Published by Wiley in The Journal of Dermatology
- Vol. 53 (5)
Lupus Erythematosus Panniculitis Patients With Overlying Discoid Lupus Erythematosus Have Higher Rates of Head and Neck Involvement Than Those Without
- 19 February 2026
- Published by Wiley in The Journal of Dermatology
- Vol. 53 (5)
Lupus Erythematosus Panniculitis Patients With Overlying Discoid Lupus Erythematosus Have Higher Rates of Head and Neck Involvement Than Those Without
- Open Access
- 8 June 2025
- Published by SAGE Publications in Lupus
- Vol. 34 (9) , 972-977
Association of truncal involvement in lupus erythematosus panniculitis patients with calcinosis cutis: A retrospective cohort study
Background: Lupus erythematosus panniculitis (LEP) is a rare variant of cutaneous lupus erythematosus that typically presents as indurated nodules or plaques. Calcinosis cutis (CC) is a potential complication of this disease with limited treatment modalities and significant quality of life complications. The rate and risk factors of CC in LEP are not well understood. Thus, we conducted a retrospective cohort study on patients diagnosed with LEP. Objective: To quantify the rate of CC and to identify the risk factors associated with its development in LEP. Methods: This retrospective cohort study analyzed data from 27 LEP patients recruited in outpatient dermatology clinics at University of Texas Southwestern Medical Center and Parkland Health from January 2009 to December 2024. The primary outcome measure was CC development based on clinical diagnosis from a dermatologist, biopsy, or radiographic imaging. Data collected included demographics, smoking history, disease duration, medications, and lesion location. Predictor variables associated with CC development were analyzed either by Mann-Whitney U or Fisher’s exact tests. Results: 10/27 (37%) LEP patients had CC during the evaluation period. LEP patients with CC had a higher rate of truncal involvement (9/10 (90%) versus 7/17 (41.2%); p = .02) and a lower rate of head & neck involvement (3/10 (30%) versus 13/17 (76.5%); p = .04) of their LEP lesions compared to those without CC. Limitations: This study is limited by its single-center design, retrospective nature, and small sample size. Conclusions: This cohort of LEP patients had over a third developing CC. LEP lesion location significantly differed in those who developed CC compared with those who did not. CC is a common complication of LEP that requires close monitoring by clinicians. Prospective multicenter studies are needed to confirm these findings and better understand the predictive factors for the development of CC in LEP patients.
- 8 June 2025
- Published by SAGE Publications in Lupus
- Vol. 34 (9) , 972-977
Open AccessAssociation of truncal involvement in lupus erythematosus panniculitis patients with calcinosis cutis: A retrospective cohort study
Background: Lupus erythematosus panniculitis (LEP) is a rare variant of cutaneous lupus erythematosus that typically presents as indurated nodules or plaques. Calcinosis cutis (CC) is a potential complication of this disease with limited treatment modalities and significant quality of life complications. The rate and risk factors of CC in LEP are not well understood. Thus, we conducted a retrospective cohort study on patients diagnosed with LEP. Objective: To quantify the rate of CC and to identify the risk factors associated with its development in LEP. Methods: This retrospective cohort study analyzed data from 27 LEP patients recruited in outpatient dermatology clinics at University of Texas Southwestern Medical Center and Parkland Health from January 2009 to December 2024. The primary outcome measure was CC development based on clinical diagnosis from a dermatologist, biopsy, or radiographic imaging. Data collected included demographics, smoking history, disease duration, medications, and lesion location. Predictor variables associated with CC development were analyzed either by Mann-Whitney U or Fisher’s exact tests. Results: 10/27 (37%) LEP patients had CC during the evaluation period. LEP patients with CC had a higher rate of truncal involvement (9/10 (90%) versus 7/17 (41.2%); p = .02) and a lower rate of head & neck involvement (3/10 (30%) versus 13/17 (76.5%); p = .04) of their LEP lesions compared to those without CC. Limitations: This study is limited by its single-center design, retrospective nature, and small sample size. Conclusions: This cohort of LEP patients had over a third developing CC. LEP lesion location significantly differed in those who developed CC compared with those who did not. CC is a common complication of LEP that requires close monitoring by clinicians. Prospective multicenter studies are needed to confirm these findings and better understand the predictive factors for the development of CC in LEP patients.
- Open Access
- 30 December 2022
- Published by Elsevier in American Journal of Transplantation
- Vol. 20 (11) , 3113-3122
Donor and transplant candidate selection for solid organ transplantation during the COVID-19 pandemic
- 30 December 2022
- Published by Elsevier in American Journal of Transplantation
- Vol. 20 (11) , 3113-3122
Open AccessDonor and transplant candidate selection for solid organ transplantation during the COVID-19 pandemic